Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 53.61B | 53.61B | 50.60B | 55.36B | 49.89B | 40.65B |
Gross Profit | 8.18B | 8.18B | 6.84B | 7.29B | 7.23B | 6.65B |
EBITDA | 4.84B | 5.20B | 4.00B | 4.50B | 3.87B | 3.75B |
Net Income | 1.54B | 1.54B | 546.00M | 977.00M | 1.40B | 1.00B |
Balance Sheet | ||||||
Total Assets | 67.86B | 67.86B | 69.94B | 67.95B | 66.49B | 58.42B |
Cash, Cash Equivalents and Short-Term Investments | 5.90B | 5.90B | 6.75B | 6.08B | 7.50B | 9.29B |
Total Debt | 28.58B | 28.58B | 30.26B | 29.94B | 28.18B | 24.59B |
Total Liabilities | 46.78B | 46.78B | 50.78B | 50.19B | 49.58B | 43.30B |
Stockholders Equity | 20.99B | 20.99B | 19.08B | 17.69B | 16.81B | 15.04B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 450.00M | 1.40B | -3.15B | -5.03B | -839.00M |
Operating Cash Flow | 0.00 | 3.30B | 3.40B | 1.70B | -572.00M | 2.46B |
Investing Cash Flow | 0.00 | -2.55B | -1.93B | -4.59B | -4.50B | -3.31B |
Financing Cash Flow | 0.00 | -1.86B | -900.00M | 1.42B | 3.11B | 1.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥19.71B | 5.74 | 5.40% | 3.11% | 12.90% | ||
80 Outperform | ¥21.87B | 11.72 | 3.14% | 2.14% | -5.12% | ||
77 Outperform | ¥19.54B | 12.02 | 2.28% | 7.57% | 35.66% | ||
76 Outperform | ¥20.11B | 9.49 | 3.80% | 11.19% | 122.83% | ||
74 Outperform | ¥17.06B | 12.23 | 2.49% | 4.46% | 25.80% | ||
68 Neutral | ¥24.91B | 10.03 | 2.83% | -1.44% | -1.26% | ||
61 Neutral | $10.27B | 6.37 | 0.76% | 2.91% | 3.10% | -36.03% |